Black seed thymoquinone improved insulin secretion, hepatic glycogen storage, and oxidative stress in streptozotocin-induced diabetic male Wistar rats

Oxidative Medicine and Cellular Longevity

Volumn 2018, Issue , 2018, Pages

  Abdelrazek, Heba M A ^a   Kilany, Omnia E ^a   Muhammad, Muhammad A A ^b   Tag, Hend M ^c   Abdelazim, Aaser M ^d,e  

^a Suez Canal University   (Egypt)

^b Suez Canal University Faculty of Medicine   (Egypt)

^c SUEZ CANAL UNIVERSITY   (Egypt)

^d Zagazig University   (Egypt)

^e UNIVERSITY OF BISHA   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

RATS;

BENEFICIAL EFFECTS; DIABETES MELLITUS; EXPERIMENTAL GROUPS; IMMUNOHISTOCHEMISTRY; INSULIN SECRETION; METABOLIC DISEASE; NIGELLA SATIVA OIL; THERAPEUTIC EFFECTS;

INSULIN;

ANTIDIABETIC AGENT; CATALASE; GLUTATHIONE; IMMUNOREACTIVE INSULIN; NIGELLA SATIVA OIL; STREPTOZOCIN; THYMOQUINONE; UNCLASSIFIED DRUG; BENZOQUINONE DERIVATIVE; INSULIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLACK CUMIN; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLYCOGEN ANALYSIS; GLYCOGEN LIVER LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; LIVER PRESERVATION; MALE; MORPHOMETRY; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS; PATHOLOGY; WISTAR RAT;

ANIMALS; CONTROL SYSTEMS; DECREMENTS; DIAMETER; PROCESSING; PROFILES; SECRETION; UPGRADING;

ANIMALS; BENZOQUINONES; DIABETES MELLITUS, EXPERIMENTAL; INSULIN; MALE; NIGELLA SATIVA; OXIDATIVE STRESS; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 85045155324     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2018/8104165     Document Type: Article

References (67)

1. P. Kumar and M. Clark, "Diabetes mellitus and other disorders of metabolism", Clinical Medicine, vol. 2, pp. 1069-1071, 2002.
2. American Diabetes Association, "Economic costs of diabetes in the U. S. in 2012", Diabetes Care, vol. 36, no. 4, pp. 1033-1046, 2013.
3. D. Luis-Rodríguez, A. Martínez-Castelao, J. L. Górriz, F. De Álvaro, and J. F. Navarro-González, "Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy", World Journal of Diabetes, vol. 3, no. 1, pp. 7-18, 2012.
4. A. Sturza, O. M. Duicu, A. Vaduva et al., "Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes", Canadian Journal of Physiology and Pharmacology, vol. 93, no. 7, pp. 555-561, 2015.
5. B. S. Karam, A. Chavez-Moreno, W. Koh, J. G. Akar, and F. G. Akar, "Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes", Cardiovascular Diabetology, vol. 16, no. 1, p. 120, 2017.
6. A. Zorzano, W. Wilkinson, N. Kotliar et al., "Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations", Journal of Biological Chemistry, vol. 264, no. 21, pp. 12358-12363, 1989.
7. A. Belfiore, F. Frasca, G. Pandini, L. Sciacca, and R. Vigneri, "Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease", Endocrine Reviews, vol. 30, no. 6, pp. 586-623, 2009.
8. S. S. Schwartz, "Optimizing glycemic control and minimizing the risk of hypoglycemia in patients with type 2 diabetes", Drugs in Context, vol. 2013, article 212255, 8 pages, 2013.
9. H. Nasri, H. Shirzad, A. Baradaran, and M. Rafieian-kopaei, "Antioxidant plants and diabetes mellitus", Journal of Research in Medical Sciences, vol. 20, no. 5, pp. 491-502, 2015.
10. S. K. Basha, G. Sudarsanam, M. S. Mohammad, and N. Parveen, "Investigations on anti-diabetic medicinal plants used by Sugali tribal inhabitants of Yerramalais of Kurnool district, Andhra Pradesh India", Stamford Journal of Pharmaceutical Sciences, vol. 4, no. 2, 2012.
11. R B. Kasetti, M. D. Rajasekhar, V. K. Kondeti et al., "Antihyperglycemic and antihyperlipidemic activities of methanol: water (4, 1) fraction isolated from aqueous extract of Syzygium alternifolium seeds in streptozotocin induced diabetic rats", Food and Chemical Toxicology, vol. 48, no. 4, pp. 1078-1084, 2010.
12. W. Goreja, Black Seed: Nature's Miracle Remedy, Amazing Herbs Press, New York, NY, USA, 2003.
13. H. Ijaz, U. R. Tulain, J. Qureshi et al., "Nigella sativa (prophetic medicine): a review", Pakistan Journal of Pharmaceutical Sciences, vol. 30, no. 1, 2017.
14. L. Canonica, G. Jommi, C. Scolastico, and A. Bonati, "The pharmacologically active principle in Nigella sativa", Gazzetta Chimica Italiana, vol. 93, pp. 1404-1407, 1963.
15. 4) induced liver toxicity in adult Wistar rats", IOSR Journal of Dental and Medical Sciences, vol. 4, no. 3, pp. 56-62, 2013.
16. M. M. Abdel-Daim and E. W. Ghazy, "Effects of Nigella sativa oil and ascorbic acid against oxytetracycline-induced hepatorenal toxicity in rabbits", Iranian Journal of Basic Medical Sciences, vol. 18, no. 3, pp. 221-227, 2015.
17. Z. Gholamnezhad, H. Rafatpanah, H. R. Sadeghnia, and M. H. Boskabady, "Immunomodulatory and cytotoxic effects of Nigella sativa and thymoquinone on rat splenocytes", Food and Chemical Toxicology, vol. 86, Supplement C, pp. 72-80, 2015.
18. A. M. S. Gani and S. A. John, "Effect of Nigella sativa L. on liver enzymes and kidney morphology on D-GalN induced toxicity in rats", World Journal of Pharmacy and Phamaceutical Sciences, vol. 5, no. 12, pp. 1193-1200, 2016.
19. H. A. El Rabey, M. N. Al-Seeni, and A. S. Bakhashwain, "The antidiabetic activity of Nigella sativa and propolis on streptozotocin-induced diabetes and diabetic nephropathy in male rats", Evidence-based Complementary and Alternative Medicine, vol. 2017, Article ID 5439645, 14 pages, 2017.
20. F. Beheshti, M. Khazaei, and M. Hosseini, "Neuropharmacological effects of Nigella sativa", Avicenna Journal ofPhytomedicine, vol. 6, no. 1, pp. 104-116, 2016.
21. A. F. Majdalawieh and M. W. Fayyad, "Recent advances on the anti-cancer properties of Nigella sativa, a widely used food additive", Journal of Ayurveda and Integrative Medicine, vol. 7, no. 3, pp. 173-180, 2016.
22. H. Hosseinzadeh and S. Parvardeh, "Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice", Phytomedicine, vol. 11, no. 1, pp. 56-64, 2004.
23. B. Meddah, R. Ducroc, M. El Abbes Faouzi et al., "Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats", Journal of Ethnopharmacology, vol. 121, no. 3, pp. 419-424, 2009.
24. Y. K. Mahmoud, S. Y. Saleh, A. Abd El Rehim, and I. A. Ibrahim, "Biochemical efficacy of Nigella sativa oil and metformin on induced diabetic male rats", American Journal of Animal and Veterinary Sciences, vol. 9, no. 4, pp. 277-284, 2014.
25. M. Balbaa, M. El-Zeftawy, D. Ghareeb, N. Taha, and A. W. Mandour, "Nigella sativa relieves the altered insulin receptor signaling in streptozotocin-induced diabetic rats fed with a high-fat diet", Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 2492107, 16 pages, 2016.
26. N. W. Tietz, Tietz Clinical Guide to Laboratory Tests, WB Saunders Company, Philadelphia, PA, USA, 1990.
27. H. Aebi, "Catalase in vitro", Methods in Enzymology, vol. 105, pp. 121-126, 1984.
28. F. Tietze, "Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues", Analytical Biochemistry, vol. 27, no. 3, pp. 502-522, 1969.
29. J. Bancroft and M. Gamble, "Hematoxylin and eosin, connective tissue and stain, carbohydrates", in Theory and Practice in Histological Techniques, p. pp. 121-186, Churchill-Livingstone, Edinburgh, 2008.
30. A. G E. Pearse, "Histochemistry", Theoretical and Applied, vol. 1, pp. 1-759, 1968.
31. S. O. Adewole and J. A. O. Ojewole, "Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats", Methods and Findings in Experimental and Clinical Pharmacology, vol. 29, no. 7, pp. 447-455, 2007.
32. R A. R. Elgawish, H. G A. Rahman, and H. M. A. Abdelrazek, "Green tea extract attenuates CCl4-induced hepatic injury in male hamsters via inhibition of lipid peroxidation and p53-mediated apoptosis", Toxicology Reports, vol. 2, Supplement C, pp. 1149-1156, 2015.
33. V. Ramakrishna and R Jailkhani, "Evaluation of oxidative stress in insulin dependent diabetes mellitus (IDDM) patients", Diagnostic Pathology, vol. 2, no. 1, p. 22, 2007.
34. T. van Bremen, D. Drömann, K. Luitjens et al., "Triggering receptor expressed on myeloid cells-1 (Trem-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsis", Diagnostic Pathology, vol. 8, no. 1, p. 24, 2013.
35. J. M. Forbes, M. T. Coughlan, and M. E. Cooper, "Oxidative stress as a major culprit in kidney disease in diabetes", Diabetes, vol. 57, no. 6, pp. 1446-1454, 2008.
36. K. Huynh, B. C. Bernardo, J. R. McMullen, and R H. Ritchie, "Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways", Pharmacology & Therapeutics, vol. 142, no. 3, pp. 375-415, 2014.
37. M. Tag Hend, M. A. Abdelazek Heba, S. Mahoud Yasmen, and S. el Shenawy Nahla, "Efficacy of Tribulus terrestris extract and metformin on fertility indices and oxidative stress of testicular tissue in streptozotocin-induced diabetic male rats", African Journal of Pharmacy and Pharmacology, vol. 9, no. 48, pp. 1088-1098, 2015.
38. N. M. Omar and G M. Atia, "Effect of Nigella sativa on pancreatic β-cell damage in streptozotocin-induced diabetic rats", The Egyptian Journal of Histology, vol. 35, no. 1, pp. 106-116, 2012.
39. K. K. Wong and E. S. Tzeng, "Appearance of different diabetic symptoms after streptozotocin administration: a comparison study", Biochemistry and Molecular Biology International, vol. 30, no. 6, pp. 1035-1041, 1993.
40. A. Dogan and L Çelik, "Healing effects of sumac (Rhus coriaria) in streptozotocin-induced diabetic rats", Pharmaceutical Biology, vol. 54, no. 10, pp. 2092-2102, 2016.
41. M. Kanter, O. Coskun, A. Korkmaz, and S. Oter, "Effects of Nigella sativa on oxidative stress and β-cell damage in streptozotocin-induced diabetic rats", The Anatomical Record, vol. 279, no. 1, pp. 685-691, 2004.
42. M. Kaleem, D. Kirmani, M. Asif, Q. Ahmed, and B. Bano, Biochemical Effects of Nigella sativa L Seeds in Diabetic Rats, 2006.
43. Z. Houcher, K. Boudiaf, M. Benboubetra, and B. Houcher, "Effects of methanolic extract and commercial oil of Nigella sativa L. on blood glucose and antioxidant capacity in alloxan-induced diabetic rats", Pteridines, vol. 18, no. 1, 2007.
44. T. Szkudelski, "The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas", Physiological Research, vol. 50, no. 6, pp. 537-546, 2001.
45. K. M. Fararh, Y. Atoji, Y. Shimizu, T. Shiina, H. Nikami, and T. Takewaki, "Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters", Research in Veterinary Science, vol. 77, no. 2, pp. 123-129, 2004.
46. H. Rchid, H. Chevassus, R Nmila et al., "Nigella sativa seed extracts enhance glucose-induced insulin release from ratisolated Langerhans islets", Fundamental & Clinical Pharmacology, vol. 18, no. 5, pp. 525-529, 2004.
47. K. M. Fararh, Y. Atoji, Y. Shimizu, and T. Takewaki, "Isulinotropic properties of Nigella sativa oil in streptozotocin plus nicotinamide diabetic hamster", Research in Veterinary Science, vol. 73, no. 3, pp. 279-282, 2002.
48. K. M. S. Mansi, "Effects of oral administration of water extract of Nigella sativa on serum concentrations of insulin and testosterone in alloxan-induced diabetic rats", Pakistan Journal of Biological Sciences, vol. 8, no. 8, pp. 1152-1156, 2005.
49. B. Krishnamurthy, J. Chee, G Jhala et al., "Complete diabetes protection despite delayed thymic tolerance in NOD8.3 TCR transgenic mice due to antigen-induced extrathymic deletion of T cells", Diabetes, vol. 61, no. 2, pp. 425-435, 2012.
50. K. A. Coughlan, R J. Valentine, N. B. Ruderman, and A. K. Saha, "AMPK activation: a therapeutic target for type 2 diabetes?", Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 7, p. 241, 2014.
51. D. F. Horrobin, "The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus", Prostaglandins, Leukotrienes, and Essential Fatty Acids, vol. 31, no. 3, pp. 181-197, 1988.
52. I. J. Goldberg, "Diabetic dyslipidemia: causes and consequences", The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 3, pp. 965-971, 2001.
53. Y. Kocyigit, Y. Atamer, and E. Uysal, "The effect of dietary supplementation of Nigella sativa L. on serum lipid profile in rats", Saudi Medical Journal, vol. 30, no. 7, pp. 893-896, 2009.
54. M. Ismail, G. Al-Naqeep, and K. W. Chan, "Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats", Free Radical Biology and Medicine, vol. 48, no. 5, pp. 664-672, 2010.
55. G. Al-Naqeeb and M. Ismail, "Regulation of apolipoprotein A-1 and apolipoprotein B100 genes by thymoquinone rich fraction and thymoquinone in HEPG2 cells", Journal of Food Lipids, vol. 16, no. 2, pp. 245-258, 2009.
56. S. Ahmad and Z. H. Beg, "Hypolipidemic and antioxidant activities of thymoquinone and limonene in atherogenic suspension fed rats", Food Chemistry, vol. 138, no. 2-3, pp. 1116-1124, 2013.
57. J. W. Baynes, "Role of oxidative stress in development of complications in diabetes", Diabetes, vol. 40, no. 4, pp. 405-412, 1991.
58. S. Tsimikas and Y. I. Miller, "Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease", Current Pharmaceutical Design, vol. 17, no. 1, pp. 27-37, 2011.
59. O. E. Kelany, H. E. Khaled, M. Amal, H. M. Abdelrazek, and M. M. Abdel-Daim, "Hepatoprotective and metabolic effects of dietary soy phytoestrogens against hyper caloric diet in cyclic female albino rats is mediated through estradiol receptors beta", Biomedical and Pharmacology Journal, vol. 10, no. 3, pp. 1061-1069, 2017.
60. I. Meral, Z. Yener, T. Kahraman, and N. Mert, "Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defence system and liver damage in experimentally-induced diabetic rabbits", Journal of Veterinary Medicine Series A, vol. 48, no. 10, pp. 593-599, 2001.
61. S. O. Adewole, E. A. Caxton-Martins, and J. A. Ojewole, "Protective effect of quercetin on the morphology of pancreatic β-cells of streptozotocin-treated diabetic rats", African Journal of Traditional, Complementary and Alternative Medicines, vol. 4, no. 1, pp. 64-74, 2007.
62. A. Gökçe, S. Oktar, A. Koc, and Z. Yonden, "Protective effects of thymoquinone against methotrexate-induced testicular injury", Human & Experimental Toxicology, vol. 30, no. 8, pp. 897-903, 2010.
63. O. A. Badary, A. B. Abdel-Naim, M. H. Abdel-Wahab, and F. M. Hamada, "The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats", Toxicology, vol. 143, no. 3, pp. 219-226, 2000.
64. G P. Widodo, R Herowati, J. M. Perangin-Angin, and J. E. Kamlasi, "Antihyperglycemic, antioxidant, and pancreas regeneration activities of black cumin (Nigella sativa L.) seeds ethanol extract in alloxan-induced diabetic rats", International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 5, pp. 37-40, 2016.
65. R H. Tuhin, M. M. Begum, M. S. Rahman et al., "Wound healing effect of Euphorbia hirta Linn. (Euphorbiaceae) in alloxan induced diabetic rats", BMC Complementary and Alternative Medicine, vol. 17, no. 1, p. 423, 2017.
66. M. G. Bischof, E. Bernroider, M. Krssak et al., "Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia", Diabetes, vol. 51, no. 1, pp. 49-54, 2002.
67. A. R. Saltiel and C. R. Kahn, "Insulin signalling and the regulation of glucose and lipid metabolism", Nature, vol. 414, no. 6865, pp. 799-806, 2001.